EUVIMEDEUVIMED entdecken
Crossref

Drug-resistant epilepsy in children post-neonatal seizures: Clinical profiles and predictors

Warisara Saenchai, Satit Manopunya, Shanika Kosarat, Varangthip Khuwuthyakorn, Watcharee Tantiprabha, Kamornwan Katanyuwong, Chinnuwat Sanguansermsri, Natrujee Wiwattanadittakul

Brain and Development · 2025

DOI: 10.1016/j.braindev.2025.104373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Development, 2025. Verfasst von Warisara Saenchai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Seizures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To investigate the clinical profile, etiologies, and outcomes of neonatal seizures and identify predictors of drug-resistant epilepsy (DRE) in children. METHOD: A retrospective chart review was performed on neonates with seizures admitted to Chiang Mai University Hospital, Thailand, from January 2008 to December 2023. The diagnosis of neonatal seizures was based on clinical findings and/or electroencephalography. Severe impairment refers to limited mobility and minimal speech, while profound impairment indicates being bedridden. DRE is defined as the failure of two antiseizure medications to control seizures. RESULTS: Among 218 patients (58.3 % male), the median seizure onset was 12 h (interquartile range [IQR]: 2.9-87 h). The leading etiology was perinatal asphyxia (58.7 %), followed by hemorrhage (7.8 %). The median follow-up was 27 months (IQR: 31.5 months). Epilepsy developed in 39 (27.3 %) patients, with 19 (48.7 %) meeting DRE criteria. Risk factors for epilepsy included marked abnormal neuroimaging, refractory neonatal seizures and severe to profound developmental impairment (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsySeizuresHumansMaleFemaleRetrospective StudiesInfant, NewbornInfantElectroencephalographyRisk FactorsChild, PreschoolAnticonvulsantsThailandDevelopmental DisabilitiesAsphyxia Neonatorum

Stichwörter der Autor:innen

Hypoxic-ischemic encephalopathy,drug-resistant epilepsyNeonatal seizuresPost‑neonatal epilepsy

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Neurology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Neurology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Electronic address: nattarujee.w@cmu.ac.th.

Zitieren

APA

Saenchai, W., Manopunya, S., Kosarat, S., Khuwuthyakorn, V., Tantiprabha, W., Katanyuwong, K., Sanguansermsri, C., & Wiwattanadittakul, N. (2025). Drug-resistant epilepsy in children post-neonatal seizures: Clinical profiles and predictors. Brain and Development. https://doi.org/10.1016/j.braindev.2025.104373

Vancouver

Saenchai W, Manopunya S, Kosarat S, Khuwuthyakorn V, Tantiprabha W, Katanyuwong K, et al. Drug-resistant epilepsy in children post-neonatal seizures: Clinical profiles and predictors. Brain and Development. 2025. doi:10.1016/j.braindev.2025.104373

BibTeX
@article{Saenchai2025,
  author = {Saenchai, Warisara and Manopunya, Satit and Kosarat, Shanika and Khuwuthyakorn, Varangthip and Tantiprabha, Watcharee and Katanyuwong, Kamornwan and Sanguansermsri, Chinnuwat and Wiwattanadittakul, Natrujee},
  title = {Drug-resistant epilepsy in children post-neonatal seizures: Clinical profiles and predictors},
  journal = {Brain and Development},
  year = {2025},
  doi = {10.1016/j.braindev.2025.104373}
}
Kostenlos starten →